Topic Hub

Jatenzo — Regulatory History

4 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.

4articles

27keywords mapped

2026-05-27latest review

Explore

Jatenzo — Regulatory History library

Showing 4 of 4 clinical reviews.

Clinical Reviews2026-05-27

Jatenzo Compounding Legal Status: FDA Approval, Label Details, and Regulatory Outlook

Complete regulatory breakdown of Jatenzo (oral testosterone undecanoate), including its FDA approval history, prescribing label specifics, compounding legal status under federal law, and what patients and clinicians need to know about access.

Read clinical review

Safety2026-05-26

Jatenzo Label Updates 2020 to 2026: FDA Safety Changes, REMS, and Prescribing Revisions

A comprehensive timeline of every FDA label change to Jatenzo (oral testosterone undecanoate) from initial approval through 2026, including REMS requirements, cardiovascular warnings, and dosing revisions.

Read clinical review

Clinical Reviews2026-05-26

Jatenzo Legal and Patent Challenges: FDA Approval, Label Disputes, and Post-Market Surveillance

A clinical review of Jatenzo (oral testosterone undecanoate) covering its FDA approval history, patent litigation, labeling requirements, REMS considerations, and ongoing legal challenges facing Tolmar.

Read clinical review

Questions2026-05-26

Jatenzo Pipeline and Next-Gen Oral Testosterone: FDA Status, Label Updates, and What Comes Next

A clinical review of Jatenzo (oral testosterone undecanoate), its FDA approval history, current label, post-market safety data, and the next-generation oral TRT pipeline.

Read clinical review